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Repeated exposure to an anxiogenic stressor (AS) is a known environmental factor for the
development of depression, yet the progression of sleep-wake (S-W) changes associated
with the onset of AS-induced depression (ASID) is not completely understood. Thus, the
aim of this study was to identify these progressive S-W changes by developing ASID in rats,
via repeated exposure to an AS, and compare this ASID-associated sleep phenotype with
the sleep phenotype of human depression. To achieve this aim, rats were first recorded
for a 6 h period of baseline S-W activity without AS. Then, rats were subjected to 5 days
of AS [Day 1: inescapable foot-shock; 5 trials of 3 s foot-shocks (1.0 mA) at 3 min intervals;
Days 3–5: 15 trials of 5 s foot-shocks at 45 s intervals]. S-W activity was recorded for 6 h
immediately after each AS treatment session. Two days later rats were again recorded for
6 h of S-W activity, but with no exposure to the AS (NASD). Compared to the baseline day:
Day 1 of AS (ASD-1) increased wakefulness, slow-wave sleep (SWS) latency, and rapid-eye
movement (REM) sleep latency, but decreased the total amount of REM sleep; ASD-2 ani-
mals remained awake throughout the 6 h S-W recording period; ASD-3, ASD-4, and ASD-5
(ASDs-3–5) decreased wakefulness, SWS latency, and REM sleep latency, but increased
the total amount of REM sleep. Interestingly, these results reveal that initial exposure to
the AS versus later, repeated exposure to the AS produced opposing S-W changes. On
NASD, animals exhibited baseline-like S-W activity, except slightly less REM sleep. These
results suggest that repeated AS produces a sleep phenotype that resembles the sleep
phenotype of depression in humans, but consistent re-exposure to the AS is required.
These results are promising because the methodological simplicity and reversibility of the
ASID-associated S-W phenotype could be more advantageous than other animal models
for studying the pathophysiological mechanisms that underlie the expression of ASID.
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INTRODUCTION
Endogenous depression is a debilitating mental health disor-
der that currently affects about 121 million people world-
wide, contributing to the loss of approximately 850,000
lives each year (http://www.who.int/mental_health/management/
depression/definition/en/). It is characterized by a multitude of
symptoms that have emotional, behavioral, and physical aspects
(Fawcett and Kravitz, 1983). The most common emotional symp-
toms include depressed mood, which persists for at least 2 weeks;
loss of interest in pleasurable activities; feelings of worthlessness
or guilt; and recurrent thoughts of death or suicide (American
Psychiatric Association,2000). The most common cognitive symp-
toms in depressed patients are difficulty thinking, concentrating,
and decision-making (Ciraulo and Shader, 2011). The most com-
mon physical symptoms are altered sleep, disruption of circadian
rhythms, fatigue, pain and discomfort, psychomotor agitation
or retardation, and appetite changes (Gerber et al., 1992). Since
depression impacts all body systems, it is not surprising that inves-
tigators have attempted to determine the effects of depression on
many biological markers, including sleep architecture, hormones,
neurotransmission, brain imaging, and immune function in order
to identify the underlying neuropathology of depression (Coble
et al., 1976; Kupfer, 1976, 1978; Gillin et al., 1979; Reynolds and
Kupfer, 1987; Kroenke and Price, 1993; Sharpley and Cowen, 1995;
Posse and Hällström, 1998; Ciraulo and Shader, 2011; Goldstein
et al., 2012).
There are many therapeutic options for treating depression
such as psychotherapy (i.e., interpersonal, psychodynamic, and
cognitive behavioral therapy; Buchheim et al., 2012), drug treat-
ment (i.e., selective serotonin reuptake inhibitors, serotonin nor-
epinephrine reuptake inhibitors, norepinephrine-dopamine reup-
take inhibitors, monoamine oxidase inhibitors, and tricyclics;
Guelfi et al., 1992; Frazer, 1997; Pinder, 1997; Matreja et al.,
2012), physical procedures (i.e., electroconvulsive therapy, Vagus
nerve stimulation, acupuncture, and repetitive transcranial mag-
netic stimulation; Rush et al., 2005; Allen et al., 2006; Rachid and
Bertschy, 2006; Gaynes et al., 2011; Martinez-Amoros et al., 2012),
and general life changes (i.e., improvements in diet, exercise, and
sleep; Bountziouka et al., 2009; Vallance et al., 2011). However,
the efficacy of these treatment options has been shown to vary
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greatly, which warrants a better understanding of the etiology and
pathophysiological mechanisms of depression and its associated
symptoms.
To better understand the pathophysiological mechanisms that
underlie these sleep-wake (S-W) disturbances, it is important to
identify an animal model of depression that emulates the sleep
phenotype commonly observed in humans with depression. In
order to achieve this understanding, a number of rat models have
been developed that simulate both endogenous (genetic and brain
chemistry alterations; e.g., neonatal drug administration, genetic
alteration) and exogenous [environmental factors; e.g., parental
separation, learned helplessness (LH)] depression (Jesberger and
Richardson, 1985; Willner, 1990; Minor et al., 1994a,b; Dugovic
et al., 2000; Mavanji et al., 2002; Kinn et al., 2008). However, none
of these models have been used previously to study the progres-
sion of S-W disturbances in depressed animals. Also, these animal
models have inherent constraints such as an elongated experi-
mental timetable, borderline ethical justification (excessive num-
ber, duration, and intensity of foot-shock), and an irreversibility
(depression cannot be eradicated once depression is acquired).
Therefore, the goal of the present study was to develop an animal
model of depression that circumvents these constraints.
Recurring exposure to an anxiogenic stressor (AS) is a major
causal factor of depression (anxiogenic stress-induced depression;
ASID). Numerous studies have utilized repetitive inescapable foot-
shock as an AS to induce depression using a range of number,
duration, and intensity of foot-shocks. Thus, in the present study,
the chosen foot-shock parameters were strong enough to induce
depression and a reversible depression-associated S-W phenotype,
but not so strong that they bordered on any ethical boundaries,
which have become increasingly stringent in recent years, as occurs
in LH studies (Adrien et al., 1991; Fogel et al., 2011). Additionally,
experimental testing was conducted in adult rats, which drasti-
cally reduced total experimental duration, compared to some of
the aforementioned animal models of depression. Also, unlike
LH which calls for a learning component to be used for assess-
ment of acquired depression, the ASID model used in the present
study incorporates no such component, thereby negating any pos-
sible effect of learning (beyond the inherent foot-shock-associated
learning) on the desired ASID-associated S-W changes. The S-W
findings of this study suggest that the method we used to induce
ASID in experimental animals indeed produced a sleep pheno-
type resembling that of human depression. A future study utilizing
this model and incorporating an avoidance learning component
could then be conducted to confirm the ASID model used in this
study does indeed produce LH, and if confirmed, this model could
then also be used to study the pathophysiological mechanisms
underlying sleep disturbances in depression.
MATERIALS AND METHODS
SUBJECTS AND HOUSING
Experiments were performed on 12 adult male Wistar rats (Charles
River Laboratories, Wilmington, MA, USA) weighing between 325
and 400 g. These rats were housed individually at 22˚C,with ad libi-
tum access to food and water, under 12 h light cycle (7:00 a.m. to
7:00 p.m.)/12 h dark cycle (7:00 p.m. to 7:00 a.m.) conditions. The
principles for the care and use of laboratory animals in research
as outlined by the National Institutes of Health Guide for the Care
and Use of Laboratory Animals (1996) were strictly followed. Addi-
tional care was taken to ensure that any potential discomfort, as
well as the number of animals used, was minimal. Also, in order
to reduce potential increases in stress imposed by experimental
handling, animals were handled daily for 15–20 min between 9:00
a.m. and 10:00 a.m. These habituation handling sessions began
1 week prior to surgery and continued up until the day of surgery.
SURGICAL PROCEDURE FOR ELECTRODE IMPLANTATION
All surgical procedures were performed stereotaxically under asep-
tic conditions in accordance with the guidelines approved by the
Institutional Animal Care and Use Committee. Animals were first
anesthetized with sodium pentobarbital (40 mg/kg, i.p.; Ovation
Pharmaceuticals,Deerfield, IL,USA), then placed in the stereotaxic
apparatus using blunt rodent ear bars and secured in the flat-skull
position, as described previously (Paxinos and Watson, 1998). The
appropriate depth of anesthesia was judged by the absence of
palpebral reflexes and a response to tail pinch. Core body tem-
perature was maintained at 37± 1˚C with a thermostatic heating
pad and a rectal thermistor probe. A scalp incision was made,
and the skin was retracted. The skull surface was then cleaned
in preparation for electrode implantation. Upon completion of
the surgical procedure, ampicillin (50 mg/rat, s.c. Bristol-Meyers
Squibb, Princeton, NJ, USA) was administered to control poten-
tial post-surgical infection and buprenorphine (0.03 mg/kg s.c.;
Ben Venue Laboratories, Bedford, OH, USA) was administered to
control potential post-operative pain.
To record vigilance states, cortical electroencephalogram (EEG;
to record cortical activity), dorsal neck muscle electromyogram
(EMG; to record neck muscle activity), and hippocampal EEG (to
record theta wave activity) recording electrodes were implanted,
as described in our earlier publications (Datta, 2000; Datta et al.,
2008). Immediately after surgery, animals were placed in recov-
ery cages and monitored for successful recovery from anesthesia
and surgery. Upon successful recovery, gaged by the return of nor-
mal postures, voluntary movement, and grooming, animals were
returned to their normal housing.
HABITUATION TO SLEEP-WAKE RECORDING CONDITIONS
After a post-surgical recovery period of 7–10 days, rats underwent
a 7 day habituation period to a sound-attenuating polygraphic
S-W recording cage (electrically shielded: 76.2× 45.7× 45.7 cm)
under free-moving conditions. The habituation period featured
daily 6 h sessions (10:00 a.m. to 4:00 p.m.) in the recording cage,
which also served as baseline recording sessions for electrode test-
ing and monitoring of daily variations in the percentages of time
spent in different S-W states. Additionally, during the recovery and
habituation periods, rats continued to experience a 12 h light/12 h
dark cycle with free access to food and water.
ANXIOGENIC STRESSOR PROCEDURE
A freezing chamber was used as the experimental apparatus. This
chamber was constructed of acrylic side walls and a Plexiglas front
wall, and included a floor consisting of stainless steel bars, which
were wired to a shock source and solid-state grid scrambler for the
delivery of foot-shocks. In the present study, the day before ASID
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treatment began was also the final day of habituation, and the S-W
recording from this day was used as the baseline S-W recording
(BLD). Starting the following day, inescapable foot-shock was used
for the induction of anxiety over a span of 5 days. At the begin-
ning of each day, naïve rats were transported from their housing
room in a clear plastic cage to the experimental testing room. On
ASD-1, within a minute upon arrival, rats were placed inside the
testing chamber (at approximately 9:40 a.m.) and were allotted
2 min of adaptation time. This was followed by five trials of 3 s
scrambled foot-shocks (1.0 mA), which occurred in fixed intervals
of 3 min, for a total of 14 min (between 9:40 a.m. and 9:55 a.m.).
On ASDs-3–5, rats were again placed in the freezing chamber and
allotted a 2 min adaptation period. Rats then received 15 trials of
5 s foot-shocks (1.0 mA once again) at 45 s intervals, for a total
of approximately 14 min (between 9:40 a.m. and 9:55 a.m.). On
each day, at the conclusion of each foot-shock session, rats were
removed from the testing chamber and connected to a polygraphic
recording system, where S-W activities were recorded for 6 h (10:00
a.m. to 4:00 p.m.). Two days after the final foot-shock session, rats
were recorded for 6 h of undisturbed S-W activity (10:00 a.m.
to 4:00 p.m.), but with no exposure to the anxiogenic stressor
(NASD). Additionally, the testing chamber was cleaned with chlo-
rine dioxide disinfectant (MB-10, Quip Laboratories, Wilmington,
DE, USA) before and after each use.
ANALYSIS OF BEHAVIORAL STATES AND CORTICAL EEG POWER
SPECTRA
For the purpose of gaging potential changes in S-W activity, poly-
graphic data were captured on-line with a computer using Gamma
software (Grass product group; Astro-Med, West Warwick, RI,
USA). From this captured data, four behavioral states were distin-
guished and scored visually using SleepSign for Animal software
(Kissei Comtec Co., Ltd, Tokyo, Japan): W, slow-wave sleep (SWS),
transitional sleep between SWS and REM sleep (tS-R), and rapid-
eye movement (REM) sleep. The physiological criteria for the
identification of these S-W states have been described in detail pre-
viously (Datta and Siwek, 2002; Datta et al., 2004; Thakkar et al.,
2008), and the scoring of these states was conducted in succes-
sive 5 s epochs. The polygraphic measures provided the following
dependent variables that were quantified for each animal: (1) per-
centage of recording time spent in W, SWS, tS-R, and REM sleep;
(2) latencies to the onset of SWS and REM sleep; and (3) total
number of REM sleep episodes. The effect of shock treatment on
the percentages of time spent in W, SWS, tS-R, and REM sleep were
statistically analyzed using a two-way ANOVA followed by Bonfer-
roni post tests, with time as a repeated-measure variable (six levels
corresponding to the six 1 h epochs of the 6 h S-W recording) and
treatment as a between-subjects variable (six levels corresponding
to the six different test days, BLD, ASD-1, ASDs-3–5, and NASD).
On ASD-2, animals did not sleep at all during the 6 h S-W record-
ing period, therefore, S-W data was not used for statistical analyses
(thus, ASD-2 S-W data is not included in any figures in this man-
uscript). One-way ANOVA and appropriate post hoc t -tests were
then performed to determine the individual levels of significant
difference in rats for each treatment day. Similar analyses were
used to analyze the latencies for SWS and REM sleep as well as the
total number of REM sleep episodes. These collective statistical
tests were performed using Prism software (GraphPad Software,
Inc., La Jolla, CA, USA).
For power spectral analysis, cortical EEG signals were amplified
and bandpass filtered (0.2–100 Hz) with a polygraph and Gamma
software, as described in our earlier publications (Maclean and
Datta, 2007; Huang et al., 2010). The amplified and filtered data
was digitized at a sampling frequency of 200 Hz and subjected to a
Fast Fourier transformation (SleepSign software) to calculate the
cortical EEG power during the total 6 h recording. Analysis focused
on two frequency ranges: delta (0.2–4.0 Hz) and theta (5–10 Hz).
The power of each frequency band was averaged and expressed
as the percentage of total power within the frequency range of
0.2–40 Hz. These two variables were then analyzed using two-way
ANOVA followed by Bonferroni post tests (Prism software).
RESULTS
EFFECTS ON SLEEP-WAKE ARCHITECTURE
Figure 1 shows the representative S-W architectures of a single rat
for the 6 h recordings (10:00 a.m. to 4:00 p.m.) that immediately
followed baseline, shock, and no shock session. These S-W archi-
tectures show that ASD-1 produced a massive increase in REM
sleep latency and fewer REM sleep episodes compared to the base-
line. Also, SWS episodes in the first 3 h were short and sporadic,
and entry into a relatively continuous level of sleep similar to that
seen on the BLD did not occur until much later in the recording.
Interestingly, later in the recording, especially during the 4 and
5 h periods, the duration of SWS episodes was notably greater in
ASD-1 than in the BLD.
ASDs-3–5 of shock treatment were fairly similar and each had
the inverse effect on REM sleep from ASD-1. There was a dras-
tic reduction in REM sleep latency and massive increase in the
number of both tS-R and REM sleep episodes, particularly in the
first 2 h of recording, compared to the BLD. Also, the duration of
REM sleep episodes was very short during the first 3 h or so of the
recording session but grew consistently longer in the final 3 h of
recording, which more closely resembled the REM sleep durations
of the BLD and ASD-1.
No exposure to the anxiogenic stressor produced little-to-no
observable effect on the overall S-W architecture compared to
the BLD. Specifically, SWS latencies, REM sleep latencies, and the
number of REM sleep episodes were all comparable. The col-
lective S-W architectures strongly indicate that the exposure to
inescapable shock drastically impacted the normal S-W activity in
rats, and that this impact was two-fold – ASD-1 had one effect,
and ASDs-3–5 produced a much different effect. Also, the lack of
stressor exposure seemed to strongly benefit the rats, as their S-W
activity returned relatively close to BLD levels.
EFFECTS ONWAKEFULNESS
Figure 2 shows the effects of shock treatment on the percent-
ages of time spent in W. A two-way ANOVA indicated a sig-
nificant main effect of treatment [F(4, 225)= 11.30, p< 0.001],
time [F(5, 225)= 76.79, p< 0.001], and treatment× time inter-
action [F(20, 225)= 2.812, p< 0.05]. Also presented in Figure 2
are the results of post hoc analyses (t -tests) on W%. These analy-
ses revealed that, compared to the BLD, the amount of time
spent in W was significantly greater on ASD-1, but significantly
www.frontiersin.org February 2013 | Volume 4 | Article 15 | 3
O’Malley et al. Anxiogenic stress and sleep phenotype of depression
FIGURE 1 | Progression of sleep-wake architecture that occurred
over the course of the six experimental test days, listed
chronologically: no exposure to anxiogenic stressor (AS) baseline
day (BLD), day 1 of AS exposure (ASD-1), day 3 of AS exposure
(ASD-3), day 4 of AS exposure (ASD-4), day 5 of AS exposure
(ASD-5), and no exposure to AS day (NASD). Each of the six
hypnograms is an example of the sleep-wake architecture expressed by
rats during the 6 h sleep-wake recording period that immediately
followed that experimental treatment. These continuous step
hypnograms plot occurrence and duration of polygraphically and
behaviorally defined wakefulness (W), slow-wave sleep (SWS),
transitional sleep between SWS and REM sleep (tS-R), and REM sleep.
less on ASDs-3–5, which were comparable with each other.
Additionally, the significant difference in W% between ASD-1
and the BLD was evident throughout the entire 6 h of record-
ing, while the differences between ASDs-3–5 with the BLD
were only present in the 1 h period. Also, W% on ASDs-3–5
was significantly reduced from that of ASD-1, and this devi-
ation was exhibited throughout the entire 6 h recording. Col-
lectively, these results indicate that stressor exposure imparted
a significant effect on the amount of time spent in W, but
that this effect triggered two distinct changes in the amount
of W.
Post hoc comparisons involving the NASD yielded results
similar to those of ASDs-3–5. Specifically, there was a sig-
nificant reduction in W% compared to the BLD, which was
present only in the 1 h period, and there was also a signif-
icant reduction in W% compared to ASD-1, which was evi-
dent throughout the entire 6 h recording. The close similar-
ity between the NASD with ASDs-3–5 indicates that the final
three consecutive days of shock treatment imparted a lasting
effect on the amount of time spent in W, and that 2 days
of relief from stressor exposure is not enough to undo this
effect.
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FIGURE 2 | Progressive effects of repetitive anxiogenic stressor (AS)
exposure on the percentages (mean±SEM) of time spent in
wakefulness for each hour of the 6h sleep-wake recording period
immediately following experimental treatment.The treatments, listed
chronologically: no exposure to AS baseline day (BLD), day 1 of AS
exposure (ASD-1), day 3 of AS exposure (ASD-3), day 4 of AS exposure
(ASD-4), day 5 of AS exposure (ASD-5), and no exposure to AS day (NASD).
*Represents a significant difference from BLD: *p<0.05, **p<0.01,
***p<0.001. ∆ represents a significant difference from ASD-1: ∆p<0.05,
∆∆p<0.01, ∆∆∆p<0.001.
EFFECTS ON SLOW-WAVE SLEEP
Figure 3 illustrates the effects of shock administration on the per-
centages of time spent in SWS per hour. A two-way ANOVA
indicated a significant main effect of time [F(5, 225)= 51.15,
p< 0.001] only. Also presented in Figure 3 are the results of
post hoc analyses (t -tests) on SWS%. These results show that
the percentage of time spent in SWS on ASD-1 was significantly
reduced during the 1 and 2 h periods compared to the BLD, and
significantly reduced during the 1 h period compared to ASDs-
3–5. Also, SWS% was markedly reduced in the 2 h period and
significantly reduced in the 3 h period on ASDs-3–4, as well as in
the 4 h period on ASD-5, compared to the BLD (ASDs-3–5 were
comparable to each other, similar to W%). These collective results
suggest that shock treatment produced deficits in the amount of
time spent in SWS, but that this deficit was expressed early on in
the recording on ASD-1 and during the middle of recording on
ASDs-3–5.
Post hoc comparisons with the NASD revealed that the amount
of time spent in SWS was comparable to that of the BLD through-
out the 6 h recording. Also, SWS% was significantly greater in the
1 and 2 h periods on the NASD compared to ASD-1. These results
suggest that 2 days of relief from shock exposure is enough to
alleviate the ASID-associated disturbances to SWS.
EFFECTS ON TRANSITIONAL SLEEP
Figure 4 represents the effects of shock and no shock sessions on
the percentages of time spent in tS-R per hour. A two-way ANOVA
indicated a significant main effect of treatment [F(4, 225)= 10.80,
p< 0.0001], time [F(5, 225)= 31.26, p< 0.0001], and treat-
ment× time interaction [F(20, 225)= 1.913, p= 0.0127]. The
detailed results of post hoc analyses (t -tests) on the total
percentages of time spent in tS-R are also presented in Figure 4.
These results revealed a marked reduction in the percentage of time
spent in tS-R in the 1 h period on ASD-1 compared to the BLD,
and significant reductions in the 2, 3, 4, 5, and 6 h periods. Also,
tS-R% values on ASDs-3–5 were comparable (similar to both W%
and SWS%), and these tS-R% values were significantly increased,
compared to the BLD and ASD-1, throughout the 6 h recording.
These results denote the large impact of shock treatment on tS-
R%, specifically the differential effect between first-time stressor
exposure, which caused a sharp reduction in tS-R% (signifying
an absence of homeostatic drive for REM sleep), and subsequent
repeated exposure, which produced a massive increase in tS-R%
(signifying an increased homeostatic drive for REM sleep).
Post hoc comparisons involving the NASD revealed that tS-
R% was significantly higher on the NASD compared to ASD-1
throughout the entire 6 h recording (similar to ASDs-3–5). How-
ever, compared to the BLD, tS-R% was significantly higher during
the 1 h period, but then comparable for the remaining 5 h of
recording (dissimilar to ASDs-3–5). These collective results sug-
gest that 2 days of relief from shock treatment is enough for tS-R
to begin to return to normal baseline levels.
EFFECTS ON REM SLEEP
The effects of shock administration on the percentages of time
spent in REM sleep per hour are depicted in Figure 5. A two-
way ANOVA indicated a significant main effect of treatment [F(4,
225)= 11.80, p< 0.0001], time [F(5, 225)= 4.50, p= 0.0006],
and treatment× time interaction [F(20, 225)= 3.78, p< 0.0001].
The detailed results of post hoc analyses (t -tests) on the total
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FIGURE 3 | Progressive effects of repetitive anxiogenic stressor (AS)
exposure on the percentages (mean±SEM) of time spent in
slow-wave sleep for each hour of the 6h sleep-wake recording period
immediately following experimental treatment.The treatments, listed
chronologically: no exposure to AS baseline day (BLD), day 1 of AS
exposure (ASD-1), day 3 of AS exposure (ASD-3), day 4 of AS exposure
(ASD-4), day 5 of AS exposure (ASD-5), and no exposure to AS day (NASD).
*Represents a significant difference from BLD: *p<0.05, **p<0.01,
***p<0.001. ∆ represents a significant difference from ASD-1: ∆p<0.05,
∆∆p<0.01, ∆∆∆p<0.001.
FIGURE 4 | Progressive effects of repetitive anxiogenic stressor (AS)
exposure on the percentages (mean±SEM) of time spent in transitional
sleep between slow-wave sleep and REM sleep for each hour of the 6h
sleep-wake recording period immediately following experimental
treatment.The treatments, listed chronologically: no exposure to AS baseline
day (BLD), day 1 of AS exposure (ASD-1), day 3 of AS exposure (ASD-3), day 4
of AS exposure (ASD-4), day 5 of AS exposure (ASD-5), and no exposure to AS
day (NASD). *Represents a significant difference from BLD: *p<0.05,
**p<0.01, ***p<0.001. ∆ represents a significant difference from ASD-1:
∆p<0.05, ∆∆p<0.01, ∆∆∆p<0.001.
percentages of time spent in REM sleep are also presented in
Figure 5. These results show that REM sleep on ASD-1 was
markedly reduced in the 1 h period and significantly reduced in
the 2, 3, 4, 5, and 6 h periods compared to the BLD. The percent-
ages of time spent in REM sleep on ASDs-3–5 were comparable
with each other (as with W%, SWS%, and tS-R%). Also, these
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FIGURE 5 | Progressive effects of repetitive anxiogenic stressor (AS)
exposure on the percentages (mean±SEM) of time spent in REM
sleep for each hour of the 6h sleep-wake recording period
immediately following experimental treatment.The treatments, listed
chronologically: no exposure to AS baseline day (BLD), day 1 of AS
exposure (ASD-1), day 3 of AS exposure (ASD-3), day 4 of AS exposure
(ASD-4), day 5 of AS exposure (ASD-5), and no exposure to AS day (NASD).
*Represents a significant difference from BLD: *p<0.05, **p<0.01,
***p<0.001. ∆ represents a significant difference from ASD-1: ∆p<0.05,
∆∆p<0.01, ∆∆∆p<0.001.
REM% values were significantly greater than those of the BLD in
the 1 and 2 h periods of recording, and significantly greater than
those of ASD-1 throughout the 6 h recording. These collective
results indicate that shock treatment imparted a large, treatment
day-specific effect on the amount of REM sleep, which suggests
two very different behavioral responses. Additionally, REM sleep
was uniquely affected during the first 2 h of the post-treatment
S-W period on ASDs-3–5, compared to the final 4 h of recording.
Specifically, the polygraphic signs of sleep revealed the presence of
muscle tone during the first 2 h, unlike during the final 4 h, which
resembled baseline-like REM sleep with complete muscle atonia.
Post hoc comparisons involving the NASD, compared to ASD-1,
revealed an increase in the percentage of time spent in REM sleep
consistent throughout the 6 h of recording (significantly higher
in the 2 h period). Compared to the BLD, REM% on NAS day
was also higher during the first 2 h of recording, but then reduced
during the last 4 h (significantly lower in the 4 and 6 h periods).
REM% on the NASD was also consistently lower than on ASDs-3–
5. Collectively, these results portray a unique behavioral response
that suggests that cessation of shock treatment alleviates some of
the ASID-induced disturbances to REM sleep, but also that traces
of these negative effects remain and require more than 2 days of
relief to be eradicated.
EFFECTS ON THE LATENCY OF SLEEP AND NUMBER OF REM SLEEP
EPISODES
The effects of repeated shock exposure were also evaluated by
measuring the latencies to the onset of both SWS and REM sleep,
as well as the total number of REM sleep episodes (Figure 6).
One-way ANOVA revealed a significant treatment effect on SWS
latency [F(5, 48)= 9.869, p< 0.0001], REM sleep latency [F(5,
46)= 47.71, p< 0.0001], and the number of REM sleep episodes
[F(5, 49)= 30.31, p< 0.0001].
Compared with the BLD (post hoc), the mean latency to the
onset of SWS was significantly longer on ASD-1, significantly
shorter on ASDs-3–5 (which were comparable with each other),
and comparable on the NASD. These results illustrate a major
response to the shock treatment, and one that is highly dependent
on whether it is a first-time exposure or re-exposure.
The results for REM sleep latency were strikingly similar to
those of SWS latency: compared with the BLD, the mean latency
to the onset of REM sleep was significantly longer on ASD-1, sig-
nificantly shorter on ASDs-3–5 (which were comparable with each
other), and comparable on the NASD. However, the levels of sta-
tistical significance in these REM sleep latency differences were
much greater than the differences in SWS latency.
Compared to the BLD, the number of REM sleep episodes
was significantly less on ASD-1, significantly greater on ASDs-3–5
(which were comparable with each other), and comparable on the
NASD. These results indicate that the frequency of REM sleep is
also impacted by shock treatment and this impact is treatment
day-specific.
EFFECTS ON THE SPECTRAL EEG POWER
The effects of repeated exposure to foot-shock on relative EEG
power in the theta and delta bands during W, SWS, and REM
sleep in the 6 h post-treatment S-W recording periods of each
experimental day were also examined. Two-way ANOVAs revealed
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FIGURE 6 | Progressive effects of repetitive anxiogenic stressor (AS)
exposure on (A) slow-wave sleep latency, (B) REM sleep latency, and
(C) total number of REM sleep episodes. Abbreviations: BLD, no
exposure to AS baseline day; ASD-1, day 1 of AS exposure; ASD-3, day 3 of
AS exposure; ASD-4, day 4 of AS exposure; ASD-5, day 5 of AS exposure;
NASD, no exposure to AS day. *Represents a significant difference from
BLD: *p< 0.05, **p<0.01, ***p<0.001. ∆ represents a significant
difference from ASD-1: ∆p<0.05, ∆∆p<0.01, ∆∆∆p< 0.001.
no significant main effect of treatment, time, or treatment× time
interaction on relative EEG power in either spectral band dur-
ing any S-W stage. Similarly, post hoc analyses of these data
revealed no significant differences between treatment days (data
not presented).
DISCUSSION
A number of the emotional, mental, and physical symp-
toms of depression can be associated with S-W dis-
turbances (Harrison and Horne, 2000; Wagner et al.,
2001;Smith and Haythornthwaite, 2004; Walker and van der
Helm, 2009). Common S-W disturbances in depression include a
decrease in REM sleep latency, greater frequency of REM sleep ear-
lier in the night, sporadic bouts of wakefulness (W), early morning
awakenings, reduced duration of stage 3 and stage 4 SWS, and
increased duration of stage 1 SWS (Coble et al., 1976; Kupfer,
1976, 1978; Gillin et al., 1979; Reynolds and Kupfer, 1987; Sharp-
ley and Cowen, 1995). The principal findings of this study are:
(1) ASD-1 increased the total percentage of time spent in W, SWS
latency, and REM sleep latency; and decreased total percentages
of time spent in SWS, tS-R, and REM sleep, and the number of
REM sleep episodes. (2) ASD-2 eliminated sleep altogether (100%
W). (3) ASDs-3–5 decreased the total percentage of time spent in
W, SWS latency, and REM sleep latency; and increased total per-
centages of time spent in tS-R and REM sleep, and the number of
REM sleep episodes. (4) On NASD, the total percentage of time
spent in SWS, SWS latency, REM sleep latency, and the number
of REM sleep episodes all reverted back to BLD levels; the total
percentages of time spent in W and tS-R remained at decreased
levels similar to ASDs-3–5; and the total percentages of time spent
in REM sleep decreased to levels between those of ASD-1 and the
BLD. Collectively, these results partly validate the ASID paradigm
used in the present study as a suitable animal model for studying
the sleep phenotype of depression, in so far as this model’s valid-
ity depends on continued stressor exposure. However, a caveat of
this interpretation is that, in the present study, we did not directly
measure the behavioral signs of depression. Thus, a future study is
needed to verify that the ASID model induces depression similar
to other animal models of depression.
The results of the present study show that after ASD-1, rats
exhibited increases in the amount of time spent in W, which were
consistent throughout the entire 6 h S-W period. This increase in
W was accompanied by increases in the latencies of SWS and REM
sleep and decreases in the amount of time spent in SWS, tS-R,
and REM sleep. On ASD-2, the loss of sleep was even more pro-
nounced. The loss of sleep and increase in W demonstrated on
these 2 days are typical characteristics of anxiety in both humans
and animals (Monti and Monti, 2000; Lavie, 2001; Ohayon and
Roth, 2003; Maclean and Datta, 2007; Pawlyk et al., 2008; Sanford
and Yang, 2010; Macone et al., 2011; Yang et al., 2011). Contrary
to the results of the present study, the previous studies that exam-
ined S-W changes associated with the LH model showed that SWS
increases after the first day of LH training (Adrien et al., 1991; Fogel
et al., 2011). This discrepancy could be explained by the fact that,
as explained in the Introduction, these two prior studies incorpo-
rated learning components, and learning and memory has been
shown to increase sleep (Karni et al., 1994; Smith, 1995; Stickgold
et al., 2000; Walker et al., 2002; Huber et al., 2004). However, a
future study is necessary to confirm this interpretation.
Contrary to ASD-1, ASDs-3–5 produced reductions in W, as
well as corresponding decreases in SWS latency and REM sleep
latency. There were also significant increases in both the amount
of time spent in REM sleep, during the first 2 h, and number of
REM sleep episodes. Interestingly, these S-W changes are typical of
those observed in human depression (Coble et al., 1976; Garcia-
Rill et al., 2008). These very similar S-W profiles on ASDs-3–5
indicate a stabilized and sustained level of S-W activity resem-
bling that of human depression. However, to our surprise, 2 days
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after the last AS session when animals were not re-exposed to the
AS, the ensuing S-W activity reflected a very different sleep pro-
file. Specifically, the amount of time spent in SWS, SWS latency,
REM sleep latency, and the number of REM sleep episodes all
returned to BLD levels. Interestingly, REM sleep during the first
2 h of recording also returned to within range of BLD levels, yet
it was significantly decreased during the latter portion of the 6 h
S-W period. Therefore, lack of re-exposure to the AS yielded S-
W parameters that did not resemble normal baseline sleep or the
S-W phenotype typical of ASID. This indicates that AS effectively
produced a depression-like sleep phenotype and that anxiety is a
necessary precursor of depression in rats.
In evaluating the significant outcome of this study, we acknowl-
edge that certain aspects of the present study could be viewed as
major limitations. The first of which is the fact that the present
study did not employ a triadic design. However, the need for this
specific design was mitigated, as the objective of this study was to
examine changes in S-W activity within the same animal. Thus,
baseline S-W activity for a specific animal served as the control S-
W data for that individual animal and was then used to compare
with that same animal’s S-W activity after exposure to an AS. Also,
a potential limitation inherent in sleep studies that employ only a
single experimental group is the fact that S-W patterns over time
are subject to sequential dependencies. However, this variable was
negated in the present study during the habituation recording ses-
sions during which rats’ S-W activity stabilized (Datta, 2000). This
ensured little-to-no day-to-day variability in S-W patterns, allow-
ing us to isolate the AS treatment-associated S-W changes. Finally,
one additional caveat of this study, as explained earlier, is the fact
that, other than S-W activity, no behavioral signs of depression
were measured to confirm depression in ASID rats.
In summary, the ASID paradigm produces a sleep phenotype
similar to that observed in humans with depression. Ultimately,
this model could be used to study the sleep phenotype and patho-
physiological mechanisms of stress-induced depression in the rat
model. However, one important factor of this model is that main-
taining a depression-like sleep phenotype in rats requires continual
exposure to the stressor, and that sudden cessation of AS expo-
sure appears to alleviate the depression-like S-W changes. This in
turn suggests that the identification and elimination of anxiety
could be a critical step for the development of behavioral and/or
pharmacological therapies for treating depression.
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